Lee, J. C., Hung, J.-Y., Kim, Y.-C., Chang, G.-C., Yoo, S., Yang, S.-H., Davis, K., Nagar, S., Taylor, A., Lee, S. and Shih, J.-Y. (2021) “Real-world Treatment Patterns in Patients with EGFR Mutation-positive NSCLC Receiving a First-Line, First- or Second-generation EGFR Tyrosine Kinase Inhibitor in South Korea and Taiwan”, Asian Pacific Journal of Cancer Biology, 6(2), pp. 123-132. doi: 10.31557/apjcb.2021.6.2.123-132.